{
    "clinical_study": {
        "@rank": "23180", 
        "acronym": "CALLAS", 
        "arm_group": {
            "arm_group_label": "metastatic colorectal cancer"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to describe the treatments received and outcomes of patients\n      with metastatic colorectal cancer,  what percentage of these patients have K-Ras mutation of\n      the tumor, and to describe the costs of treatments. Information will also be collected\n      regarding risk factors, variables among treatment centers and patients, and explorative\n      analyses will be done to try to identify factors that impact prognosis and factors that\n      predict tolerability and response to treatment."
        }, 
        "brief_title": "Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras", 
        "completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Metastatic Colorectal Cancer", 
        "condition_browse": {
            "mesh_term": "Colorectal Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologic diagnosis colorectal carcinoma\n\n          -  Metastatic disease\n\n          -  Signed informed consent\n\n        Exclusion Criteria:\n\n          -  Prior treatment of metastatic colorectal cancer\n\n          -  Refusal or incapability of providing informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients at participating Institutes who are candidate for first-line treatment of\n        metastatic colorectal cancer"
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01651013", 
            "org_study_id": "CALLAS"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 3, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Benevento", 
                        "country": "Italy"
                    }, 
                    "name": "A.O.G. Rummo"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Napoli", 
                        "country": "Italy"
                    }, 
                    "name": "Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento Entero-proctologico"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nocera Inferiore", 
                        "country": "Italy"
                    }, 
                    "name": "Ospedale Civile Umberto I"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rionero in Vulture", 
                        "country": "Italy"
                    }, 
                    "name": "C:R.O. Regione Basilicata Ospedale Giustino Fortunato"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "1", 
        "official_title": "Multicentered Observational Prospective Cohort Study on the Treatment of Metastatic Colorectal Cancer and the Role of Evaluating K-Ras", 
        "other_outcome": [
            {
                "measure": "metastatic colorectal cancer treatments used in clinical practice, according to participating center", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "patient outcome according to K-Ras status", 
                "safety_issue": "No", 
                "time_frame": "two years"
            }, 
            {
                "measure": "estimated costs per treatment per center", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "disease outcome per patient per treatment received", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "exploratory analyses", 
                "measure": "factors that influence patient prognosis", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "exploratory analyses", 
                "measure": "predictive factors for response to treatment", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }
        ], 
        "overall_contact": {
            "email": "francesco.perrone@usc-intnapoli.net", 
            "last_name": "Francesco Perrone, M.D., Ph.D.", 
            "phone": "+39 081 5903571"
        }, 
        "overall_contact_backup": {
            "email": "marilina.piccirillo@usc-intnapoli.net", 
            "last_name": "Marilina Piccirillo, M.D.", 
            "phone": "+39 081 5903383"
        }, 
        "overall_official": [
            {
                "affiliation": "National Cancer Institute, Naples", 
                "last_name": "R. V. Iaffaioli, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "National Cancer Institute, Naples", 
                "last_name": "G. Nasti, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "National Cancer Institute, Naples", 
                "last_name": "M. C. Piccirillo, M.D.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "percentage of patients enrolled in a clinical trial", 
                "safety_issue": "No", 
                "time_frame": "two years"
            }, 
            {
                "measure": "percentage of patients who undergo K-Ras mutation study", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "Percentage of patients with K-Ras mutation", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01651013"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Cancer Institute, Naples", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Cancer Institute, Naples", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2010", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}